ORGO Insider Trading (Organogenesis)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 57.20%

Insider Buying (Last 12 Months): $3,999,094.76

Insider Selling (Last 12 Months): $3,281,101.41

Organogenesis Insider Trading History Chart

Organogenesis Share Price & Price History

^$16.41

▲ +1.2 (7.89%)

As of 03/1/2021 01:00 AM ET

Days: 30 | 90 | 365

World's 2nd Richest Man Is About To Shock The World

From Legacy Research | Ad

Elon Musk changed online payment processing with Paypal. He's changing space exploration with SpaceX and the auto industry...

See what Elon is up to now.

Organogenesis Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/18/2021	Gary S Gillheeney	CEO	Sell	16,663	$12.85	$214,119.55	245,845
2/16/2021	Gary S Gillheeney	CEO	Sell	111,406	$13.12	$1,461,646.72	416,954
2/11/2021	Gary S Gillheeney	CEO	Sell	69,127	$13.82	$955,335.14	416,954
2/11/2021	Glenn H Nussdorf	Director	Sell	200,000	$3.25	$650,000.00	68,594,976
12/2/2020	Wayne D Mackie	Director	Buy	38,710	$5.26	$203,614.60	200,000
11/24/2020	Avista Capital Managing Member	Director	Buy	100	$5.00	$500.00
11/19/2020	Avista Capital Managing Member	Director	Buy	36,127	$4.97	$179,551.19
11/17/2020	Michael W Katz	Major Shareholder	Buy	20,829	$3.25	$67,694.25	34,432
11/17/2020	Wayne D Mackie	Director	Buy	42,726	$3.25	$138,859.50	161,290
3/16/2020	Avista Capital Managing Member	Director	Buy	542,349	$3.92	$2,126,008.08
3/12/2020	Avista Capital Managing Member	Director	Buy	332,349	$3.86	$1,282,867.14
11/26/2019	Avista Capital Managing Member	Director	Buy	6,000,000	$5.00	$30,000,000.00
9/13/2019	Michael W Katz	Major Shareholder	Buy	3,603	$6.00	$21,618.00
9/12/2019	Avista Capital Managing Member	Director	Buy	860,900	$5.99	$5,156,791.00
9/10/2019	Avista Capital Managing Member	Director	Buy	537,000	$5.18	$2,781,660.00
9/5/2019	Alan A Ades	Director	Buy	105,100	$4.50	$472,950.00	67,896,723
9/4/2019	Michael W Katz	Major Shareholder	Buy	10,000	$4.50	$45,000.00	10,000
9/3/2019	Arthur S Leibowitz	Director	Buy	5,000	$4.20	$21,000.00	5,000

SEC Filings (Institutional Ownership Changes) for Organogenesis (NASDAQ:ORGO)

4.62% of Organogenesis stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Organogenesis Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/19/2021	JPMorgan Chase & Co.	62,726	$0.47M	0.0%	+317.5%	0.058%
2/17/2021	Wealth Dimensions Group Ltd.	60,900	$0.46M	0.4%	N/A	0.057%
2/16/2021	Walleye Trading LLC	50,098	$0.38M	0.0%	N/A	0.046%
2/16/2021	Walleye Capital LLC	108,834	$0.82M	0.1%	N/A	0.101%
2/16/2021	Zacks Investment Management	83,705	$0.63M	0.0%	N/A	0.078%
2/16/2021	Pura Vida Investments LLC	1,807,554	$13.61M	0.5%	N/A	1.677%
2/16/2021	Nuveen Asset Management LLC	81,957	$0.62M	0.0%	+76.3%	0.076%
2/16/2021	New York Life Investments Alternatives	124,263	$0.94M	0.6%	N/A	0.115%
2/16/2021	Avidity Partners Management LP	5,521,500	$41.58M	1.3%	N/A	5.123%
2/16/2021	Gyon Technologies Capital Management LP	35,453	$0.27M	0.1%	N/A	0.033%
2/16/2021	Charles Schwab Investment Management Inc.	359,626	$2.71M	0.0%	+117.1%	0.334%
2/13/2021	American International Group Inc.	13,955	$0.11M	0.0%	+15.3%	0.013%
2/12/2021	Laurion Capital Management LP	562,980	$4.24M	0.0%	N/A	0.522%
2/12/2021	Federated Hermes Inc.	10,406	$78K	0.0%	+80.7%	0.010%
2/11/2021	Lazard Asset Management LLC	9,840	$74K	0.0%	+754.2%	0.009%
2/11/2021	Northern Trust Corp	332,596	$2.50M	0.0%	+23.5%	0.309%
2/11/2021	Barclays PLC	13,142	$99K	0.0%	-10.0%	0.012%
2/11/2021	Citigroup Inc.	4,176	$31K	0.0%	+329.6%	0.004%
2/10/2021	Rhumbline Advisers	14,088	$0.11M	0.0%	+14.3%	0.013%
2/10/2021	Renaissance Technologies LLC	646,300	$4.87M	0.0%	+237.0%	0.600%
2/9/2021	Wells Fargo & Company MN	63,200	$0.48M	0.0%	+110.9%	0.059%
2/9/2021	Bank of New York Mellon Corp	97,030	$0.73M	0.0%	+73.6%	0.090%
2/8/2021	Alliancebernstein L.P.	35,500	$0.27M	0.0%	+17.2%	0.033%
2/5/2021	BlackRock Inc.	1,264,397	$9.52M	0.0%	+19.5%	1.173%
2/4/2021	State of Wisconsin Investment Board	15,000	$0.11M	0.0%	-11.2%	0.014%
1/29/2021	Emerald Mutual Fund Advisers Trust	1,846,153	$13.90M	0.5%	N/A	1.713%
1/29/2021	Emerald Advisers LLC	3,500	$26K	0.0%	N/A	0.003%
1/27/2021	CWM LLC	4,000	$30K	0.0%	+66.8%	0.004%
11/16/2020	Squarepoint Ops LLC	67,502	$0.26M	0.0%	+227.4%	0.063%
11/16/2020	ArrowMark Colorado Holdings LLC	11,832	$45K	0.0%	-57.5%	0.011%
11/13/2020	Morgan Stanley	13,600	$52K	0.0%	-32.0%	0.013%
11/13/2020	Charles Schwab Investment Management Inc.	165,676	$0.64M	0.0%	+10.8%	0.154%
11/12/2020	JPMorgan Chase & Co.	15,024	$58K	0.0%	-17.9%	0.014%
11/10/2020	State Street Corp	259,014	$1M	0.0%	+33.2%	0.246%
11/6/2020	BlackRock Inc.	1,057,985	$4.06M	0.0%	-0.4%	1.004%
11/6/2020	GSA Capital Partners LLP	16,953	$65K	0.0%	N/A	0.016%
11/2/2020	Hussman Strategic Advisors Inc.	100,000	$0.38M	0.1%	-50.0%	0.095%
9/15/2020	Two Sigma Advisers LP	52,900	$0.20M	0.0%	-6.2%	0.050%
8/25/2020	Nuveen Asset Management LLC	46,000	$0.18M	0.0%	+75.2%	0.044%
8/20/2020	Charles Schwab Investment Management Inc.	149,480	$0.58M	0.0%	+21.4%	0.142%
8/17/2020	Jane Street Group LLC	14,874	$57K	0.0%	N/A	0.014%
8/14/2020	Prosight Management LP	535,616	$2.06M	0.9%	-20.3%	0.508%
8/12/2020	Bank of Montreal Can	130,974	$0.44M	0.0%	+5.5%	0.123%
8/12/2020	American International Group Inc.	12,379	$48K	0.0%	+74.7%	0.012%
8/12/2020	Goldman Sachs Group Inc.	54,576	$0.21M	0.0%	+202.3%	0.051%
8/12/2020	Bank of New York Mellon Corp	55,338	$0.21M	0.0%	+95.0%	0.052%
6/19/2020	State Street Corp	171,788	$0.56M	0.0%	+4.3%	0.162%
5/15/2020	Squarepoint Ops LLC	80,706	$0.26M	0.0%	+31.1%	0.076%
5/15/2020	Morgan Stanley	18,461	$60K	0.0%	+23.2%	0.017%
5/15/2020	Two Sigma Investments LP	46,761	$0.15M	0.0%	-45.1%	0.044%
5/15/2020	Two Sigma Advisers LP	56,400	$0.18M	0.0%	+71.4%	0.053%
5/15/2020	Prosight Management LP	672,275	$2.17M	1.0%	+8.8%	0.634%
5/14/2020	Wells Fargo & Company MN	10,368	$33K	0.0%	-41.4%	0.010%
5/14/2020	Geode Capital Management LLC	242,105	$0.78M	0.0%	+21.9%	0.230%
5/14/2020	Alliancebernstein L.P.	16,000	$52K	0.0%	N/A	0.015%
5/12/2020	Granahan Investment Management Inc. MA	285,990	$0.92M	0.0%	+14.4%	0.271%
5/12/2020	JPMorgan Chase & Co.	20,028	$65K	0.0%	+41.3%	0.019%
5/11/2020	State Street Corp	171,788	$0.56M	0.0%	+4.3%	0.163%
5/11/2020	Private Advisors LLC	45,013	$0.15M	0.1%	+17.8%	0.043%
5/1/2020	BlackRock Inc.	651,085	$2.10M	0.0%	+3.7%	0.618%
2/20/2020	Geode Capital Management LLC	198,579	$0.96M	0.0%	+12.7%	0.210%
2/14/2020	Marshall Wace LLP	37,418	$0.18M	0.0%	N/A	0.039%
2/14/2020	Goldman Sachs Group Inc.	19,131	$92K	0.0%	N/A	0.020%
2/14/2020	UBS Group AG	13,560	$65K	0.0%	+30.2%	0.014%
2/13/2020	Laurion Capital Management LP	25,000	$0.12M	0.0%	N/A	0.026%
2/13/2020	K2 Principal Fund L.P.	89,191	$0.43M	0.0%	N/A	0.094%
2/13/2020	Renaissance Technologies LLC	35,300	$0.17M	0.0%	N/A	0.037%
2/12/2020	Monashee Investment Management LLC	115,818	$0.56M	0.5%	+577.2%	0.122%
2/10/2020	Barclays PLC	16,324	$79K	0.0%	+214.3%	0.017%
2/10/2020	Bank of Montreal Can	117,068	$0.56M	0.0%	+12,569.7%	0.124%
2/7/2020	Tower Research Capital LLC TRC	12,034	$58K	0.0%	N/A	0.013%
2/7/2020	Charles Schwab Investment Management Inc.	116,488	$0.56M	0.0%	+97.7%	0.123%
2/6/2020	Guild Investment Management Inc.	42,845	$0.21M	0.3%	N/A	0.045%
2/6/2020	State Street Corp	164,760	$0.79M	0.0%	+30.9%	0.174%
2/5/2020	New York State Common Retirement Fund	5,400	$26K	0.0%	-60.0%	0.006%
2/3/2020	Private Advisors LLC	38,203	$0.18M	0.2%	N/A	0.040%
1/31/2020	Hussman Strategic Advisors Inc.	200,000	$0.96M	0.3%	N/A	0.211%
11/27/2019	State Street Corp	125,843	$0.83M	0.0%	+2.3%	0.133%
8/14/2019	Citadel Advisors LLC	26,312	$0.20M	0.0%	N/A	0.029%
8/14/2019	Vanguard Group Inc.	323,292	$2.46M	0.0%	+33.3%	0.354%
8/13/2019	BlackRock Inc.	554,838	$4.22M	0.0%	+716.3%	0.607%
8/13/2019	Northern Trust Corp	41,066	$0.31M	0.0%	+134.3%	0.045%
8/12/2019	Bank of New York Mellon Corp	27,545	$0.21M	0.0%	N/A	0.030%
8/10/2019	Charles Schwab Investment Management Inc.	86,495	$0.66M	0.0%	+36.6%	0.095%
6/30/2019	Moors & Cabot Inc.	91,350	$0.69M	0.1%	N/A	0.100%

Data available starting January 2016

Organogenesis Holdings Inc., a regenerative medicine company, focuses on the development, manufacture, and commercialization of solutions for the advanced wound care, and surgical and sports medicine markets primarily in the United States. The company's advanced wound care products include Apligraf for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft for treating DFUs; PuraPly AM to address biofilm across a range of wound types; and Affinity and NuShield to address various wound sizes and types. Its surgical and sports medicine products comprise ReNu for in-office joint and tendon applications; NuCel for bony fusion in the spine and extremities; NuShield and Affinity for surgical applications in targeted soft tissue repairs; and PuraPly AM for the surgical treatment of open wounds. The company's pipeline products include TransCyte for the treatment of second- and third-degree burns; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; Novachor for the treatment of chronic and acute wounds; Gintuit for the treatment of mucogingival conditions in adults; and PuraPly XT and PuraPly MZ for the treatment of chronic and acute wounds, as well as for surgical treatment of open wounds. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician offices. The company sells its products through direct sales representatives and independent agencies. Organogenesis Holdings Inc. was founded in 1985 and is headquartered in Canton, Massachusetts.

Today's Range

Now: $16.41

$14.69

$16.74

50 Day Range

MA: $11.72

$7.34

$15.21

52 Week Range

Now: $16.41

$2.47

$16.74

Volume

1,155,253 shs

Average Volume

924,484 shs

Market Capitalization

$1.77 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.84

Who are the company insiders with the largest holdings of Organogenesis?

Organogenesis' top insider shareholders include:

Glenn H Nussdorf (Director)
Alan A Ades (Director)
Gary S Gillheeney (CEO)
Wayne D Mackie (Director)
Michael W Katz (Major Shareholder)
Arthur S Leibowitz (Director)
Avista Capital Managing Member (Director)

Who are the major institutional investors of Organogenesis?

Organogenesis' top institutional investors include:

Avidity Partners Management LP — 5.12%
Emerald Mutual Fund Advisers Trust — 1.71%
Pura Vida Investments LLC — 1.68%
BlackRock Inc. — 1.17%
Renaissance Technologies LLC — 0.60%
Laurion Capital Management LP — 0.52%

Which institutional investors are selling Organogenesis stock?

During the previous quarter, ORGO stock was sold by these institutional investors:

State of Wisconsin Investment Board
Barclays PLC

In the previous year, company insiders that have sold Organogenesis company stock include:

Glenn H Nussdorf (Director)
Alan A Ades (Director)

Which institutional investors are buying Organogenesis stock?

During the last quarter, ORGO stock was acquired by institutional investors including:

Avidity Partners Management LP
Emerald Mutual Fund Advisers Trust
Pura Vida Investments LLC
Laurion Capital Management LP
Renaissance Technologies LLC
BlackRock Inc.
Charles Schwab Investment Management Inc.
New York Life Investments Alternatives

In the previous year, these company insiders have bought Organogenesis stock:

Glenn H Nussdorf (Director)
Alan A Ades (Director)
Gary S Gillheeney (CEO)
Wayne D Mackie (Director)
Michael W Katz (Major Shareholder)